Rockeby Biomed Limited ASX: RBY - September 2007 Quarterly - Dr Sze Wee Tan, Chief Executive
Sydney, Oct 24, 2007 (ABN Newswire) - Rockeby Biomed Limited (ASX: RBY) - September 2007 Quarterly - Dr Sze Wee Tan, Chief Executive; Rockeby Biomed Limited (ASX: RBY) present the following audio webcast regarding "September 2007 Quarterly". You may also download this audio webcast to your computer or portable audio player.
Broadcaster: Rockeby Biomed Limited (ASX: RBY)
Broadcast Title: September 2007 Quarterly
Broadcast Type: Audio stream
Audio webcast Link:
Listen to the Audio stream and view the announcement for Rockeby Biomed Limited (ASX: RBY) below.
http://abnnewswire.net/vlnk/H16X0Z1D
This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Minimum requirement for playing the multimedia links are; at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player. In addition, some media links contain material requiring the ability to run Flash Multimedia.
About ROCKEBY BIOMED LIMITED
Rockeby biomed Limited is an ASX-listed (ASX: RBY) biotechnology company engaged primarily in the research, development and marketing of products for the diagnosis and treatment of fungal infections in humans. The company's main market is that of in-vitro diagnostic testing which covers serology tests in hospitals as well as point-of-care products for use by consumers or health professionals operating outside hospitals.
